Skip to main content
SpringerLink
Log in

Long-term suppression of lymphangitic lung metastasis from breast cancer using biweekly docetaxel: A case report

  • Case Report
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

A 45-year-old woman underwent a modified radical mastectomy for right breast cancer in July 1996. As lymph node metastases were quite advanced, chemotherapy was started with anthracyclines. Four years after surgery, cough and dyspnea appeared. Chest radiograph and CT showed reticular shadows bilaterally and slight pleural effusion, suggesting lymphangitic lung metastasis of breast cancer. Biweekly intravenous docetaxel (TXT, 45 mg/m2) was initiated. Four courses of TXT ameliorated her complaints and radiographic findings. A total of 30 continuous courses of TXT suppressed disease exacerbation for 18 months until new lesions manifested in January 2002. The main side effects were grade 2 leukopenia and alopecia. This case report describes a patient with long-term suppression of lymphangitic lung metastasis of breast cancer using biweekly TXT without severe side effects or worsening quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bruce DM, Heys SD, Eremin O: Lymphangitis carcinomatosa: A literature review.J R Coll Surg Edinb 41:7–13, 1996.

    PubMed  CAS  Google Scholar 

  2. Sadoff L, Grossman J, Weiner H: Lymphangitic pulmonary metastasis secondary to breast cancer with normal chest x-rays and abnormal perfusion lung scans.Oncology 31:164–171, 1975.

    PubMed  CAS  Google Scholar 

  3. Adachi I: Clinical studies on the treatment of the advanced breast cancer with lung metastasis.Gan To Kagaku Ryoho 9:972–978, 1982 (in Japanese with English abstract).

    PubMed  CAS  Google Scholar 

  4. Valero V, Holmes FA, Walters RS: Phase II trial of docetaxel: A new highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.J Clin Oncol 13:2886–2894, 1995.

    PubMed  CAS  Google Scholar 

  5. Salminen E, Bergman M, Huhtala S, Jekunen A, Ekholm E: Docetaxel, a promising novel chemotherapeutic agent in advanced breast cancer.Anticancer Res 20:3663–3668, 2000.

    PubMed  CAS  Google Scholar 

  6. Dieras V, Chevallier B, Kerbrat P, Krakowski I, Roche H, Misset JL, Lentz MA, Azli N, Murawsky M, Riva A, Pouillart P, Fumoleau P: A multicentre phase II study of docetaxel 75 mg/m2 as first line chemotherapy for patients with advanced breast cancer: Report of the Clinical Screening Group of the EORTC.Br J Cancer 74:650–656, 1996.

    PubMed  CAS  Google Scholar 

  7. Kreisman H, Wolkove N, Finkelstein HS, Cohen C, Margolese R, Frank H: Breast cancer and thoracic metastasis: Review of 119 patients.Thorax 38:175–179, 1983.

    Article  PubMed  CAS  Google Scholar 

  8. Munk PL, Muller NL, Miller RR, Ostrow DN: Pulmonary lymphangitic carcinomatosis: CT and pathologic findings.Radiology 166:705–709, 1988.

    PubMed  CAS  Google Scholar 

  9. Stein MG, Mayo J, Muller N, Aberle DR, Webb WR, Gamsu G: Pulmonary lymphangitc spread of carcinoma: Appearance on CT scans.Radiology 162:371–375, 1987.

    PubMed  CAS  Google Scholar 

  10. Schimmel DH, Julien PJ, Gamsu G: Resolution of pulmonary carcinoma of the breast.Chest 69:106–108, 1976.

    Article  PubMed  CAS  Google Scholar 

  11. Hamilton CR, Plowman PN: Prolonged remission of lymphangitis carcinomatosis from breast cancer.Br J Dis Chest 81:400–403, 1987.

    Article  PubMed  CAS  Google Scholar 

  12. Verweij J, Clavel M, Chevalier B: Paclitaxel (Taxol) and docetaxel (Taxotere): Not simply two of a kind.Ann Oncol 5:495–505, 1994.

    PubMed  CAS  Google Scholar 

  13. Burstein H, Manola J, Younger J, Parker LM, Bunnell CA, Scheib R, Matulonis UA, Garber JE, Clarke KD, Shulman LN, Winer EP: Docetaxel administered on a weekly basis for metastatic breast cancer.J Clin Oncol 18:1212–1219, 2000.

    PubMed  CAS  Google Scholar 

  14. Aihara T, Kim Y, Takatusuka Y: Phase II study of weekly docetaxel in patients with metastatic breast cancer.Ann Oncol 13:286–292, 2002.

    Article  PubMed  CAS  Google Scholar 

  15. Shin E, Ishitobi M, Hiraoka M, Fujitani K, Mishima H, Nishisho I, Sawamura T, Hasuike Y, Tsujinaka T: Phase I study of docetaxel administration by biweekly infusion to patients with metastatic breast cancer.Anticancer Res 20:4721–4726, 2000

    PubMed  CAS  Google Scholar 

  16. Kuroi K, Bando H, Saji S, Toi M: Weekly schedule of docetaxel in breast cancer: Evaluation of response and toxicity.Breast Cancer 10:10–14, 2003.

    Article  PubMed  Google Scholar 

  17. Adachi I, Watanabe T, Takashima S, Narabayahsi M, Horikoshi N, Aoyama H, Taguchi T: A late phase II study of PR56976 (docetaxel) in patients with advanced or recurrent breast cancer.Br J Cancer 73:210–216, 1996.

    PubMed  CAS  Google Scholar 

  18. Ninomiya J, Horiguchi J, Koibuchi Y, Yokoe T, lino Y, Morishita Y: Phase I study of biweekly docetaxel in patients with metastatic breast cancer.Proc Jpn Breast Cancer Soc 2002, A-053 (in Japanese).

  19. Rubens RD: Management of advanced breast cancer.Int J Clin Pract 55:676–679, 2001.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Surgery, Gunma University Faculty of Medicine, 3-39-15, Showa-machi, Maebashi, 371-8511, Gunma, Japan

    Jun Ninomiya, Jun Horiguchi, Yukio Koibuchi, Takashi Yoshida, Kotaro lijima, Miho Yoshida, Daisuke Takata & Yasuo Morishita

  2. Department of Emergency and Critical Care Medicine, Gunma University Faculty of Medicine, Japan

    Takao Yokoe & Yuichi lino

Authors
  1. Jun Ninomiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Horiguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yukio Koibuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kotaro lijima
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Miho Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Daisuke Takata
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takao Yokoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yuichi lino
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yasuo Morishita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Ninomiya.

About this article

Cite this article

Ninomiya, J., Horiguchi, J., Koibuchi, Y. et al. Long-term suppression of lymphangitic lung metastasis from breast cancer using biweekly docetaxel: A case report. Breast Cancer 10, 361–365 (2003). https://doi.org/10.1007/BF02967658

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02967658

Key words

Search

Navigation